The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2024 | Continuity of care for patients with hematological predispositions to AML
Anupama Rao, MD, Great Ormond Street Hospital, London, UK, shares insights into examples of recognized hematological predispositions to acute myeloid leukemia (AML) – Runt-related transcription factor 1 familial platelet disorder (RUNX1-FPD) and Shwachman-Diamond syndrome. Considering RUNX1-FPD, which is often diagnosed in newborn babies, Dr Rao reflects on the key clinical questions that must be answered and the necessity of continuity of care and disease monitoring from infancy to adulthood due to the risk of transformation to AML. In the case of Shwachman-Diamond syndrome, a rare, multi-system disorder of inherited bone marrow failure, Dr Rao emphasizes the importance of coordinated multi-specialist care. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Medical Advisory Board: RUNX1 group.
